Bronchial asthma: An integrated approach to patient care

##plugins.themes.academic_pro.article.main##

Hemant Budania1, Amit Choudhary1, Komal Lamba1, Deshraj Lamba1, Anisha1, Navita1, Manoj Kumar Sharma2, Rajkamal Sharma3*

Abstract

Bronchial asthma is a chronic inflammatory disease of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. These symptoms can range from mild to severe and can significantly impact the quality of life of affected individuals. Asthma not only poses a substantial burden on patients and their families, but also exerts considerable pressure on healthcare systems globally due to its prevalence, morbidity, and the need for ongoing management and treatment. This article aims to explore an integrated approach to patient care in bronchial asthma, encompassing multiple dimensions such as pathophysiology, environmental and genetic factors, diagnosis, and comprehensive management strategies. Understanding the pathophysiology of asthma, including the chronic inflammation and remodeling of the airways, is crucial for developing effective treatment plans (Barnes, 2008). Environmental factors, such as allergens and air pollution, as well as genetic predisposition, play significant roles in the development and exacerbation of asthma symptoms (Brunekreef & Holgate, 2002; Holloway, Yang, & Holgate, 2010). Diagnosis of asthma involves a detailed medical history, physical examination, lung function tests, and identification of specific triggers through allergy testing (Pellegrino et al., 2005). Spirometry is a key diagnostic tool used to measure airflow limitation and its reversibility with bronchodilators. Biomarkers are also increasingly being used to assess and monitor inflammation levels. Management strategies for asthma are multifaceted and include pharmacotherapy, trigger avoidance, patient education, regular monitoring, and lifestyle modifications (Bousquet et al., 2010; NHLBI, 2007). Pharmacotherapy primarily involves the use of inhaled corticosteroids (ICS) to reduce inflammation and prevent exacerbations, with additional medications such as long-acting beta-agonists (LABAs), leukotriene modifiers, and biologics used for more severe cases (Bousquet et al., 2010). Avoiding known triggers, such as allergens and pollutants, is essential in preventing asthma attacks. Educating patients about their condition, proper inhaler techniques, and self-management strategies is vital for improving adherence to treatment and overall disease control (Jones, 2008). Regular monitoring of lung function and routine follow-ups help in adjusting treatment plans and preventing exacerbations (GINA, 2020). Encouraging a healthy lifestyle, including regular physical activity and weight management, can also positively impact asthma control (Pedersen & Saltin, 2006). By adopting a holistic approach to asthma care, healthcare providers can better address the complexities of the disease and improve patient outcomes. Ongoing research and innovation are crucial for developing new therapies and refining existing treatment protocols to enhance the quality of life for individuals living with asthma (Schatz & Rosenwasser, 2014).


 


Keywords: Bronchial Asthma, Diagnosis, Management, Treatment.


 

##plugins.themes.academic_pro.article.details##

How to Cite
Hemant Budania1, Amit Choudhary1, Komal Lamba1, Deshraj Lamba1, Anisha1, Navita1, Manoj Kumar Sharma2, Rajkamal Sharma3*. (2024). Bronchial asthma: An integrated approach to patient care. International Journal of Medical Science in Clinical Research and Review, 7(06), Page: 1303–1308. Retrieved from http://ijmscrr.in/index.php/ijmscrr/article/view/956